what they said (Hover the mouse cursor over underlined words for more info)
NEW YORK - Hormone therapy should still be offered and can benefit younger women go i n g t h rough menopause, members of the International Menopause Society conclude in updated treatment recommendations.
" The safety of hormone therapy largely depends on age," Dr. Amos Pines of Ichilov Hospital in Tel Aviv and IMS colleagues write in a consensus statement published in the journal Climacteric. " Women younger than 60 years old should not be concerned about the safety profile of hormone therapy."
Bus, they add, hormones should be given in the lowest possible dose and only given if needed to resolve symptoms. Women taking hormone therapy should see a doctor at least once a year....
what we said (Hover the mouse cursor over underlined words for more info)
This article is based upon a reanalysis of a 2002 study which documented significant adverse events for women on hormone replacement therapy. The 2002 study was not designed to determine if there is a difference between the adverse events experienced by women in various age groups. Sorting the data in new ways, to find differences "after the fact", is unacceptable research methodology which violates basic scientific principles. Therefore, the statement "women younger than 60 years old should not be concerned about the safety profile of hormone therapy" is irresponsible and dangerous. Many questions about the conflict of interest of the single source cited are not addressed in this article.